283 related articles for article (PubMed ID: 26559740)
1. Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation.
Antunes HS; Schluckebier LF; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Rampini MP; Ferreira EM; Dias FL; Teich V; Teich N; Ferreira CG
Oral Oncol; 2016 Jan; 52():85-90. PubMed ID: 26559740
[TBL] [Abstract][Full Text] [Related]
2. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis.
Antunes HS; Herchenhorn D; Small IA; Araújo CMM; Viégas CMP; de Assis Ramos G; Dias FL; Ferreira CG
Oral Oncol; 2017 Aug; 71():11-15. PubMed ID: 28688677
[TBL] [Abstract][Full Text] [Related]
4. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
5. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
6. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy--a randomized controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Nigudgi S
Support Care Cancer; 2013 May; 21(5):1421-8. PubMed ID: 23224689
[TBL] [Abstract][Full Text] [Related]
7. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
[TBL] [Abstract][Full Text] [Related]
8. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.
Tsujimoto T; Yamamoto Y; Wasa M; Takenaka Y; Nakahara S; Takagi T; Tsugane M; Hayashi N; Maeda K; Inohara H; Uejima E; Ito T
Oncol Rep; 2015 Jan; 33(1):33-9. PubMed ID: 25351453
[TBL] [Abstract][Full Text] [Related]
9. Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patients - a triple blinded randomized controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Vadhiraja BM
Radiother Oncol; 2012 Sep; 104(3):349-54. PubMed ID: 22884841
[TBL] [Abstract][Full Text] [Related]
10. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients.
Oton-Leite AF; Silva GB; Morais MO; Silva TA; Leles CR; Valadares MC; Pinezi JC; Batista AC; Mendonça EF
Lasers Surg Med; 2015 Apr; 47(4):296-305. PubMed ID: 25824475
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of cisplatin-based chemoradiation to treat patients with unresectable, nonmetastatic head and neck cancer in Brazil.
Brentani A; de Castro G; Federico MH
Head Neck; 2011 Aug; 33(8):1199-205. PubMed ID: 21755563
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
13. Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients-a randomized placebo controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Guddattu V
J Photochem Photobiol B; 2015 Mar; 144():51-6. PubMed ID: 25704314
[TBL] [Abstract][Full Text] [Related]
14. Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols.
Zecha JA; Raber-Durlacher JE; Nair RG; Epstein JB; Elad S; Hamblin MR; Barasch A; Migliorati CA; Milstein DM; Genot MT; Lansaat L; van der Brink R; Arnabat-Dominguez J; van der Molen L; Jacobi I; van Diessen J; de Lange J; Smeele LE; Schubert MM; Bensadoun RJ
Support Care Cancer; 2016 Jun; 24(6):2793-805. PubMed ID: 26984249
[TBL] [Abstract][Full Text] [Related]
15. Low level helium neon laser therapy for chemoradiotherapy induced oral mucositis in oral cancer patients - a randomized controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya GA
Oral Oncol; 2012 Sep; 48(9):893-7. PubMed ID: 22502814
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer.
Daly ME; Lau DH; Farwell DG; Luu Q; Donald PJ; Chen AM
Am J Otolaryngol; 2013; 34(6):631-5. PubMed ID: 23954137
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of head and neck cancer.
Diaz-Sanchez RM; Pachón-Ibáñez J; Marín-Conde F; Rodríguez-Caballero Á; Gutierrez-Perez JL; Torres-Lagares D
Med Oral Patol Oral Cir Bucal; 2015 May; 20(3):e378-85. PubMed ID: 25662553
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness randomized clinical trial on the effect of photobiomodulation therapy for prevention of radiotherapy-induced severe oral mucositis in a Brazilian cancer hospital setting.
Lopes Martins AF; Nogueira TE; Morais MO; de Sousa-Neto SS; Oton-Leite AF; Valadares MC; Aires Freitas NM; Leles CR; Mendonça EF
Support Care Cancer; 2021 Mar; 29(3):1245-1256. PubMed ID: 32621262
[TBL] [Abstract][Full Text] [Related]
19. Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients.
Sonis ST; Hashemi S; Epstein JB; Nair RG; Raber-Durlacher JE
Oral Oncol; 2016 Mar; 54():7-14. PubMed ID: 26852286
[TBL] [Abstract][Full Text] [Related]
20. Low-level laser therapy dosimetry most used for oral mucositis due to radiotherapy for head and neck cancer: a systematic review and meta-analysis.
Peralta-Mamani M; da Silva BM; da Silva Pinto AC; Rubira-Bullen IRF; Honório HM; Rubira CMF; da Silva Santos PS
Crit Rev Oncol Hematol; 2019 Jun; 138():14-23. PubMed ID: 31092370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
